A major generic drug approval bulletin for today. If you are the parent of a child who suffers from attention deficit hyperactivity disorder (usually called “ADHD”) or suffer from ADHD yourself, this one is sure of interest you. Last week, U.S. District Court Judge Dennis M. Cavanaugh ruled that Eli Lilly and Company’s patent on . . . → Read More: Generic Drug Alert: Patent on Strattera Ruled Invalid, Generic Versions Of Strattera to Hit the Market